Ann: Cancet Spodumene Remote Sensing Study, page-52

I would like to see that too, but there's going to be a lot more shares on issue soon Patience. At this price we'd double it to 220k shares just to raise $1.5m. The only consolation is that we'd have to vote on an issue larger than, I think it's around 10% of current shares isn't it, as per ASX listing rules? If looking to Wuxi Baichuan to recapitalise the company, their share of the company could easily increase to a controlling stake, taking the chair and at least one more seat on the Board. My share would be heavily diluted but I'd be more confident in the prospects of the company going forward.